About LeadClient

From Fen-Phen to PFAS.
We’ve done it.

LeadClient has been generating plaintiff cases since 1999 — through every major mass tort docket of the past quarter century, in partnership with the leadership firms running them. Cases sourced through our operation have produced more than $2 billion in bellwether verdicts.

$2B+ In bellwether verdicts on cases sourced through our operation
10%+ Of plaintiffs in many major MDL & JCCP dockets, past two decades
600K+ Cases retained by plaintiff firms since 1999
25+ yrs Continuous case generation, Fen-Phen to PFAS

The plaintiff bar deserves a real operating partner.

LeadClient exists because the plaintiff bar’s most serious dockets deserve more than a vendor relationship. There is no shortage of legal-focused agencies and intake shops; what is rare is an operator with twenty-five years of continuous experience generating, screening, and advancing cases that perform. Every claimant we deliver is measured the same way: did this case meet the firm’s criteria, did it survive pre-litigation, did it advance through the docket, did it prove compensable?

Our work has accounted for over 10% of plaintiffs in many of the most significant MDL and JCCP dockets of the past two decades, and cases sourced through our operation have gone on to produce more than $2 billion in bellwether verdicts. We work primarily with the leadership firms running those dockets, their referrers, and the litigation funds capitalizing them.

What that produces over time is a different kind of relationship. The partners we work with don’t treat us as a vendor they manage; they treat us as an operating function they integrate with. Embedded with their teams, accountable to their standards, measured by their outcomes. That is the work, and it is what we have spent 25+ years getting right.

Track record

Twenty-five years of cases.
Two billion in bellwether verdicts.

We measure ourselves by what the cases we source go on to do for the firms that take them.

Cases sourced through our acquisition operation have produced more than $2 billion in bellwether verdicts across federal MDL and California JCCP proceedings. Bellwether outcomes shape settlement value for the entire docket — and the firms running those bellwethers are the firms we partner with.

Our work has accounted for more than 10% of plaintiffs in many of the most significant MDL and JCCP proceedings of the past two decades. We measure ourselves by the share of compensable plaintiffs we put into the dockets that matter.

From Fen-Phen to PFAS, we have sourced cases in every major mass tort wave of the past quarter century — under continuous founder ownership, with the same commitment to operating discipline and partner-level relationships that we started with in 1999.

Continuity

Same founder. Same firm.
Twenty-five years and counting.

The economics of mass tort case generation are genuinely difficult, and most shops in this category eventually run into the wall of that math. When they do, partners and clients are usually the first to absorb the damage — case commitments unmet, balances written off, relationships abandoned. Some operations reopen under a new name. Others get acquired — by larger holding companies, occasionally by private equity — and their own profitability becomes even more of a focus. None of those outcomes produce the partner continuity that the firms running serious dockets actually need.

LeadClient has operated under the same founder ownership and the same operating leadership since 1999. The partners we serve today include firms we started working with in the Fen-Phen and Vioxx eras. Continuity is not a marketing claim — it is the structural precondition for the kind of partnership a serious plaintiff firm can rely on across cycles.

Docket history

Every major mass tort wave since 1999.

We have run media and intake for plaintiff firm clients across every consequential mass tort docket of the past quarter century — through Fen-Phen, the Vioxx era, the medical device waves, the pharmaceutical and herbicide dockets, and into the PFAS and social media generation.

1999
Fen-Phen Diet drug pulmonary hypertension and valvular heart disease litigation. The first major mass tort acquisition operation we ran.
2002
Vioxx Cardiovascular injury claims arising from Merck's COX-2 inhibitor. Multi-district litigation through 2007 settlement.
2007
Trasylol Renal failure and mortality claims related to Bayer's surgical anti-bleeding agent.
2010
Transvaginal mesh Multi-defendant pelvic mesh litigation. One of the largest medical device MDLs in U.S. history, exceeding 100,000 plaintiffs.
2014
Talc / ovarian cancer Johnson & Johnson talcum powder litigation. Bellwether verdicts established the framework for nationwide settlement discussions.
2016
Roundup / glyphosate Monsanto/Bayer non-Hodgkin lymphoma litigation. Bellwether verdicts in the Bay Area set the standard for the broader settlement.
2018
Hernia mesh C.R. Bard, Atrium, and Ethicon hernia repair device litigation. Multiple consolidated MDLs across federal court.
2022
Camp Lejeune Federal claims under the Camp Lejeune Justice Act for service members and families exposed to contaminated water.
2022
Social media MDL Adolescent mental-health claims against Meta, TikTok, Snap, and YouTube. Active in the Northern District of California.
2023
Hair relaxer Uterine cancer claims arising from chemical hair relaxer products. Active MDL in the Northern District of Illinois.
2024 →
PFAS & the next wave PFAS personal injury, AFFF firefighter foam, and the emerging dockets that the next decade of plaintiff work will be built on.
Selected dockets · not exhaustive
How we’re built

One of the first.
Still one of the only.

LeadClient is one of the first plaintiff legal marketing operations to bring every function of the case acquisition process in-house. Twenty-five years later, the operation still runs the same way — full stack, one roof, under continuous founder ownership since 1999.

Under one roof: two fully dedicated media teams with search, social, native, display, and CTV expertise; U.S.-based intake, pre-litigation, and docket management teams; proprietary lead screening software and case management systems; a multi-vendor fraud-detection and lead-validation stack; and ethics counsel on retainer. No offshore call centers. No white-label vendors. No pieces farmed out to third parties whose incentives don’t match yours.

Quality at the front of the funnel determines quality at the back. We’ve made structural choices that make competing on price impossible — and that’s the point. We don’t chase the bottom of the market, and we don’t generate cases for firms that do. Some of the firms we work with today have been our partners for over twenty-five years, and that continuity is the strongest possible proof that the model works.

Ethics & compliance

Compliance is shared exposure.
We treat it that way.

When a plaintiff legal marketing operation runs ads on a firm’s behalf, both parties are accountable. The firm operates under state bar oversight on the legal side; we operate under TCPA, CAN-SPAM, CCPA, HIPAA, and state AG regimes on the marketing side. Reputation in the partner-firm community travels fast on either side of a violation. A compliance failure damages everyone associated with the docket — which is why we treat compliance as structural to whether the work is worth doing at all.

We retain outside ethics counsel in multiple states and screen every campaign through compliance review before launch. We monitor state-by-state attorney advertising rule changes and state privacy laws — CCPA and the growing patchwork of similar regimes — and update operating procedures the day rules change. TCPA and DNC scrubbing happen before any claimant reaches an intake call. CAN-SPAM compliance is built into every email touchpoint. HIPAA-compliant infrastructure is the only environment our intake operation has ever used.

Attorney advertising compliance is the line we don’t cross, and we’ve never asked a partner to cross it on our behalf. This standard is twenty-five years old at this point — older than most of the agencies our partners are evaluating today. It is part of why some of those partners have been working with us for decades.

Leadership

The people behind the work.

LeadClient is led by an operating team that has spent careers in plaintiff legal marketing — not consultants who arrived recently.

Our properties

An operating company, not just an agency.

Beyond LeadClient itself, we operate a portfolio of consumer-facing and industry properties that support our case acquisition work.

SelectJustice.com Consumer
Our flagship consumer-facing property for mass tort case intake. Profiled by TikTok for Business; their case study on Select Justice contributed to the platform opening to legal marketing.
Works closely with plaintiff firms to find capital solutions, talent, projects, and partnerships — helping great lawyers grow and operate great law firms.
AttorneyAtLaw.com Industry
A premier legal industry property and home of the Verdict Awards program, including the Billion Dollar Bar award for plaintiff firms.
Where we’re active

In the room where the bar gathers.

Member, sponsor, and presenter at the conferences and associations that define the plaintiff bar.

American Association for Justice (AAJ) — member of the largest plaintiff trial lawyer association in the country. We’re in the room with the lawyers, not just selling to them.

Mass Torts Made Perfect (MTMP) — one of the most important plaintiff bar conferences. We attend, sponsor, and present.

Trial Lawyers of Mass Torts (TLMT) — peer network where mass tort dockets are discussed before they exist on anyone’s radar. Active member.

Legal Marketing Association (LMA) — the discipline-side professional organization. We treat marketing as a serious craft, not an executional afterthought.

Office & contact

Where to find us.

Carlsbad, California. LeadClient is headquartered in coastal Southern California. We work with partner firms across all 50 states.

Email: contact@leadclient.com
For partners: Speak with our team →

Start a conversation.
Speak with our team.

A LeadClient case-acquisition strategist will reach out to talk through your docket.